NDC 43772-0052

Vaxosode

Echinacea (angustifolia), Baptisia Tinctoria, Chelidonium Majus, Hydrastis Canadensis, Phytolacca Decandra, Tabebuia Impetiginosa, Taraxacum Officinale, Uncaria Tomentosa, Thuja Occidentalis, Calcarea Carbonica, Silicea, Belladonna, Chamomilla, Lycopodium Clavatum, Rhus Tox, Arsenicum Album, Pertussinum

Vaxosode is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Synergy Formulas, Inc.. The primary component is Echinacea Angustifolia; Baptisia Tinctoria Root; Chelidonium Majus; Goldenseal; Phytolacca Americana Root; Tabebuia Impetiginosa Bark; Taraxacum Officinale; Cat's Claw; Thuja Occidentalis Leafy Twig; Oyster Shell Calcium Carbonate, Crude; Silicon Dioxide; Atropa Belladonna; Matricaria Recutita; Lycopodium Clavatum Spore; Toxicodendron Pubescens Leaf; Arsenic Trioxide; Human Sputum, Bordetella Pertussis Infected.

• Product ID: 43772-0052_cda54fe6-29c5-4a32-ab05-2942384c5988
• NDC: 43772-0052
• Product Type: Human Otc Drug
• Proprietary Name: Vaxosode
• Generic Name: Echinacea (angustifolia), Baptisia Tinctoria, Chelidonium Majus, Hydrastis Canadensis, Phytolacca Decandra, Tabebuia Impetiginosa, Taraxacum Officinale, Uncaria Tomentosa, Thuja Occidentalis, Calcarea Carbonica, Silicea, Belladonna, Chamomilla, Lycopodium Clavatum, Rhus Tox, Arsenicum Album, Pertussinum
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2015-03-19
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Synergy Formulas, Inc.
• Substance Name: ECHINACEA ANGUSTIFOLIA; BAPTISIA TINCTORIA ROOT; CHELIDONIUM MAJUS; GOLDENSEAL; PHYTOLACCA AMERICANA ROOT; TABEBUIA IMPETIGINOSA BARK; TARAXACUM OFFICINALE; CAT'S CLAW; THUJA OCCIDENTALIS LEAFY TWIG; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SILICON DIOXIDE; ATROPA BELLADONNA; MATRICARIA RECUTITA; LYCOPODIUM CLAVATUM SPORE; TOXICODENDRON PUBESCENS LEAF; ARSENIC TRIOXIDE; HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED
• Active Ingredient Strength: 1 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 43772-0052-1

60 mL in 1 BOTTLE, DROPPER (43772-0052-1)

• Marketing Start Date: 2015-03-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 43772-0052-1 [43772005201]

Vaxosode LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-03-19
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
ECHINACEA ANGUSTIFOLIA	1 [hp_X]/mL

OpenFDA Data

• SPL SET ID: 2971790f-1689-4f17-b1f9-fa970a635cee
• Manufacturer:
  • Synergy Formulas, Inc.
• UNII:
  • 39981FM375
  • 5EF0HWI5WU
  • ETJ7Z6XBU4
  • C88X29Y479
  • 6IO182RP7A
  • ZW3Z11D0JV
  • 2E32821G6I
  • 7E889U5RNN
  • WQZ3G9PF0H
  • U364V64HUN
  • S7V92P67HO
  • 6GLA1946WX
  • 11E6VI8VEG
  • G0R4UBI2ZZ
  • 9060PRM18Q
  • 1NT28V9397
  • VB06AV5US8